The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

Recent headlines suggest that up to 42% of people ages 55 and older face an eventual dementia diagnosis. But some experts have a follow-up message: Risk isn't the same as destiny, and there are ways ...

Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimer’s disease in 2033.

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Diet, exercise, brain games, even using your non-dominant hand can help prevent the onset of Alzheimer's disease.

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...